© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Margaret A. Liu (Vice President, Vaccines Research, Chiron Corporation) reviews a wide range of approaches to vaccine design and development. Consideration is given to the particular strengths and ...

US biotechnology company Chiron (Emeryville, CA) has agreed to buy PathoGenesis (Seattle, WA) for around $700 million in an all-cash deal that provides Chiron with revenue from a high-growth ...

In an increasingly competitive industry, Chiron Capital falls behind on a number of key metrics, resulting in a Below Average Parent Pillar rating. Fees on the firm's open-end and exchange-traded ...